These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 20487225

  • 1. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin.
    Gao A, Wang X, Xiang W, Liang H, Gao J, Yan Y.
    J Pharm Pharmacol; 2010 Mar; 62(3):393-9. PubMed ID: 20487225
    [Abstract] [Full Text] [Related]

  • 2. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
    Xiang W, Gao A, Liang H, Li C, Gao J, Wang Q, Shuang B, Zhang J, Yan Y, Wang X.
    Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007
    [Abstract] [Full Text] [Related]

  • 3. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells.
    Jiang J, Wang X, Cheng K, Zhao W, Hua Y, Xu C, Yang Z.
    Mol Med Rep; 2016 Jun; 13(6):4745-50. PubMed ID: 27082231
    [Abstract] [Full Text] [Related]

  • 4. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C, Guan X, Xue H, Wang P, Wang M, Gai X.
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [Abstract] [Full Text] [Related]

  • 5. Reversal effects of two new milbemycin compounds on multidrug resistance in MCF-7/adr cells in vitro.
    Gao A, Liang H, Wang X, Zhang X, Jing M, Zhang J, Yan Y, Xiang W.
    Eur J Pharmacol; 2011 Jun 01; 659(2-3):108-13. PubMed ID: 21458446
    [Abstract] [Full Text] [Related]

  • 6. Reversal effects of Rabdosia rubescens extract on multidrug resistance of MCF-7/Adr cells in vitro.
    Li F, Fan J, Wu Z, Liu RY, Guo L, Dong Z, Wang Z.
    Pharm Biol; 2013 Sep 01; 51(9):1196-203. PubMed ID: 23777360
    [Abstract] [Full Text] [Related]

  • 7. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM, Liang YJ, Ruan JW, Ding Y, Wang XW, Shi Z, Gu LQ, Yang XP, Fu LW.
    J Pharm Pharmacol; 2004 Aug 01; 56(8):1061-6. PubMed ID: 15285852
    [Abstract] [Full Text] [Related]

  • 8. Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells.
    Hien TT, Kim HG, Han EH, Kang KW, Jeong HG.
    Mol Nutr Food Res; 2010 Jul 01; 54(7):918-28. PubMed ID: 20077420
    [Abstract] [Full Text] [Related]

  • 9. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX, Yang XH.
    Yao Xue Xue Bao; 2008 May 01; 43(5):461-6. PubMed ID: 18717331
    [Abstract] [Full Text] [Related]

  • 10. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
    Li J, Xu LZ, He KL, Guo WJ, Zheng YH, Xia P, Chen Y.
    Breast Cancer Res; 2001 May 01; 3(4):253-63. PubMed ID: 11434876
    [Abstract] [Full Text] [Related]

  • 11. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
    Shi R, Peng H, Yuan X, Zhang X, Zhang Y, Fan D, Liu X, Xiong D.
    J Cell Biochem; 2013 Aug 01; 114(8):1890-900. PubMed ID: 23494858
    [Abstract] [Full Text] [Related]

  • 12. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin.
    Qi X, Chang Z, Song J, Gao G, Shen Z.
    Anticancer Drugs; 2011 Jul 01; 22(6):556-62. PubMed ID: 21637162
    [Abstract] [Full Text] [Related]

  • 13. A novel indirubin derivative PHII-7 potentiates adriamycin cytotoxicity via inhibiting P-glycoprotein expression in human breast cancer MCF-7/ADR cells.
    Shi R, Li W, Zhang X, Zhang Y, Peng H, Xie Y, Fan D, Liu R, Liu X, Xiong D.
    Eur J Pharmacol; 2011 Nov 01; 669(1-3):38-44. PubMed ID: 21871878
    [Abstract] [Full Text] [Related]

  • 14. Ergosterol reverses multidrug resistance in SGC7901/Adr cells.
    Hu X, Jiang D, Li F, Wu Z, Huang Y, Song S, Wang Z.
    Pharmazie; 2014 May 01; 69(5):396-400. PubMed ID: 24855835
    [Abstract] [Full Text] [Related]

  • 15. [Effects of schisandrin B on reversing multidrug resistance in human breast cancer cells transfected with mdr1 gene].
    Li L, Wang T, Xu ZL, Yu Y, Chen W, Chen F.
    Zhonghua Yi Xue Za Zhi; 2005 Jun 22; 85(23):1633-7. PubMed ID: 16185533
    [Abstract] [Full Text] [Related]

  • 16. Reversal of P-glycoprotein-mediated multidrug resistance is induced by mollugin in MCF-7/adriamycin cells.
    Tran TP, Kim HG, Choi JH, Na MK, Jeong HG.
    Phytomedicine; 2013 May 15; 20(7):622-31. PubMed ID: 23466342
    [Abstract] [Full Text] [Related]

  • 17. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.
    Wang J, Qu H, Jin L, Zeng W, Qin L, Zhang F, Wei X, Lu W, Zhang C, Liang W.
    J Pharm Sci; 2011 Jun 15; 100(6):2267-77. PubMed ID: 21246559
    [Abstract] [Full Text] [Related]

  • 18. Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol.
    Xu D, Lu Q, Hu X.
    Cancer Lett; 2006 Nov 18; 243(2):274-80. PubMed ID: 16406853
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Euphorbia factor L1 reverses ABCB1-mediated multidrug resistance involving interaction with ABCB1 independent of ABCB1 downregualtion.
    Zhang JY, Mi YJ, Chen SP, Wang F, Liang YJ, Zheng LS, Shi CJ, Tao LY, Chen LM, Chen HB, Fu LW.
    J Cell Biochem; 2011 Apr 18; 112(4):1076-83. PubMed ID: 21308736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.